161 related articles for article (PubMed ID: 2198750)
1. Large scale ivermectin distribution and its epidemiological consequences.
Remme J; De Sole G; Dadzie KY; Alley ES; Baker RH; Habbema JD; Plaisier AP; van Oortmarssen GJ; Samba EM
Acta Leiden; 1990; 59(1-2):177-91. PubMed ID: 2198750
[TBL] [Abstract][Full Text] [Related]
2. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM
Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591
[TBL] [Abstract][Full Text] [Related]
3. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus.
Remme J; Baker RH; De Sole G; Dadzie KY; Walsh JF; Adams MA; Alley ES; Avissey HS
Trop Med Parasitol; 1989 Sep; 40(3):367-74. PubMed ID: 2617046
[TBL] [Abstract][Full Text] [Related]
4. The Onchocerciasis Control Programme in West Africa (OCP).
Boatin B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():13-7. PubMed ID: 18718148
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological impact of vector control. I. Incidence and changes in prevalence and intensity of Onchocerca volvulus infection.
De Sole G; Remme J; Dadzie KY
Acta Leiden; 1990; 59(1-2):119-26. PubMed ID: 2378200
[TBL] [Abstract][Full Text] [Related]
6. A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitologic findings after three treatments.
Somo RM; Ngosso A; Dinga JS; Enyong PA; Fobi G
Am J Trop Med Hyg; 1993 Jan; 48(1):9-13. PubMed ID: 8427394
[TBL] [Abstract][Full Text] [Related]
7. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
9. Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
Koala L; Nikiema A; Post RJ; Paré AB; Kafando CM; Drabo F; Traoré S
Acta Trop; 2017 Feb; 166():96-105. PubMed ID: 27845063
[TBL] [Abstract][Full Text] [Related]
10. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
11. [The use of ivermectin in the control of onchocerciasis].
Chippaux JP; Boussinesq M; Prod'hon J
Sante; 1995; 5(3):149-58. PubMed ID: 7640897
[TBL] [Abstract][Full Text] [Related]
12. The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana.
Alley ES; Plaisier AP; Boatin BA; Dadzie KY; Remme J; Zerbo G; Samba EM
Trans R Soc Trop Med Hyg; 1994; 88(5):581-4. PubMed ID: 7992347
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials.
De Sole G; Remme J; Awadzi K; Accorsi S; Alley ES; Ba O; Dadzie KY; Giese J; Karam M; Keita FM
Bull World Health Organ; 1989; 67(6):707-19. PubMed ID: 2633886
[TBL] [Abstract][Full Text] [Related]
14. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
Awadzi K; Dadzie KY; Kläger S; Gilles HM
Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
[TBL] [Abstract][Full Text] [Related]
16. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
17. Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal.
Njongmeta LM; Nfon CK; Gilbert J; Makepeace BL; Tanya VN; Trees AJ
Int J Parasitol; 2004 Aug; 34(9):1069-74. PubMed ID: 15313133
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin in onchocerciasis control in the forest zone of Cote d'Ivoire.
Soungalo T; Soumana D; Moussa S; François R
Acta Trop; 1997 Dec; 68(3):297-300. PubMed ID: 9492914
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.
Dadzie KY; Awadzi K; Bird AC; Schulz-Key H
Trop Med Parasitol; 1989 Sep; 40(3):355-60. PubMed ID: 2694314
[TBL] [Abstract][Full Text] [Related]
20. Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment.
Mweya CN; Kalinga AK; Kabula B; Malley KD; Ruhiso MH; Maegga BT
Tanzan Health Res Bull; 2007 Sep; 9(3):174-9. PubMed ID: 18087895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
